MSD TENDER NUMBERS CLOSING ON 07/07/2020 at 10.

00 am
TENDER NO   ITEM QUANTITY PACK DELIVERY
SIZE
2204 LP/MSD/CPU- MSD O/L No 2020/SPC/B/R/P/00403 1,590 01 IMMEDIATELY with
DHS/RQ/189/(E)/2020 CAP 15 months Residual
SR No 01106601 caps
Shelf Life
Item Acitretin capsule 10mg  

Specification Acitretin capsule 10mg  

2205 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00406 1 01 IMMEDIATELY with

DHS/NRQ/190/ VIAL 15 months Residual
(E)/2020 SR No 00802901 VIAL
Shelf Life
Item C1 Esterase inhibitor (Recombinant) powder for  
solution vial 2100 U

Specification C1 Esterase inhibitor (Recombinant) powder for  

solution vial 2100U
2206 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00407 15 01 IMMEDIATELY with
DHS/NRQ/191/ TAB 15 months Residual
(E)/2020 SR No 00307602 TABS
Shelf Life
Item Enzyme Co Q10 tablet 100mg  
Specification Enzyme Co Q10 tablet 100mg  
Each tablet to contain 100mg of Enzyme Co Q10
2207 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00410 255 01 IMMEDIATELY with
 DHS/NRQ/192/ SR No 00113201 TABS TAB 15 months Residual
(E)/2020 Shelf Life
Item Inosine pranobex tablet 500mg  
Specification Inosine pranobex tablet 500mg  

2208 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00411 240 01 IMMEDIATELY with

DHS/RQ/193/(E)/2020 SR No 01209503 caps CAP 15 months Residual
Item Isotretinoin Capsule 20mg   Shelf Life

Specification Isotretinoin Capsule 20mg  

Each capsule to contain 20mg of isotretinoin
Note:
01.The shelf life of the product should be minimum of
24 months.
2209 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00412 1 01 IMMEDIATELY with
DHS/RQ/194/(E)/2020 SR No 00305903 bot BOT 15 months Residual
Item Levetiracetam Oral Solution 100mg /ml in 300ml Bottle   Shelf Life

Specification Levetiracetam Oral Solution 100mg /ml in 300ml Bottle  

each bottle to contain 100mg /ml Levetiracetam
BP/USP
Note:
01.The shelf life of the product should be minimum of
24 months
2221 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00424 36 01 IMMEDIATELY with
DHS/NRQ/206/(E)/2020 SR No 00307601 caps CAP 15 months Residual
 Item Enzyme Co Q10 capsule 100mg  
Specification Enzyme Co Q10 capsule 100mg   Shelf Life

2222 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00425 270 01 IMMEDIATELY with

DHS/NRQ/207/(E)/2020 SR No 00404203 TABS TAB 15 months Residual
Item Carnitine 500mg tablet   Shelf Life

Specification Carnitine 500mg tablet  

2223 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00426 30 01 IMMEDIATELY with
DHS/NRQ/208/(E)/2020 SR No 00109802 TABS TAB 15 months Residual
Item Ribavirin tablet 200mg   Shelf Life

Specification Ribavirin Tablet 200mg  

2224 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00429 21 01 IMMEDIATELY with
DHS/RQ/209/(E)/2020 SR No 01402802 VIALS VIAL 15 months Residual
Item Secukinumab injection150mg/ml powder for solution   Shelf Life
Specification Secukinumab injection150mg/ml powder for solution  
2225 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00432 360 01 IMMEDIATELY with
DHS/RQ/210/(E)/2020 SR No 00108601 TABS TAB 15 months Residual
Item Tenofovir Disoproxil Fumarate Tablets 300mg   Shelf Life

Specification Tenofovir Disoproxil Fumarate Tablets 300mg  

2226 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00438 53 01 IMMEDIATELY with
DHS/RQ/211/(E)/2020 SR No 01210201 VIALS VIAL 15 months Residual
Item Azacitidine injection 100mg vial   Shelf Life

Specification Azacitadine Injection 100mg vial,  

Each vial to contain 100mg of Azacitadine for
subcutaneous and intravenous use.
Note:
1.The product should be stable for 24 months when
stored at a temperature of 28'C-32'C.
2. Each vial should be labelled accordingly
2227 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00441 1,170 01 IMMEDIATELY with
DHS/RQ/212/(E)/2020 SR No 00108601 TABS TAB 15 months Residual
Item Tenofovir Disoproxil Fumarate Tablets 300mg   Shelf Life

Specification Tenofovir Disoproxil Fumarate Tablets 300mg  

2228 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00442 40 01 IMMEDIATELY with
DHS/RQ/213/(E)/2020 SR No 01401401 VIALS VIAL 15 months Residual
Item Adalimumab injection 40mg   Shelf Life
Specification Adalimumab injection 40mg  
2229 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00443 4 01 IMMEDIATELY with
 DHS/NRQ/214/(E)/2020 SR No 01401801 bot BOT 15 months Residual
Item Zoledronic acid Injection 5mg in 100ml bottle   Shelf Life
Specification Zoledronic acid Injection 5mg in 100ml Bottle  

2230 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00446 12 01 IMMEDIATELY with

DHS/RQ/215/(E)/2020 SR No 01402802 VIALS VIAL 15 months Residual
Item Secukinumab injection150mg/ml powder for solution   Shelf Life
Specification Secukinumab injection150mg/ml powder for solution  
2232 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00390 360 01 IMMEDIATELY with
DHS/RQ/217/(E)/2020 SR No 01205605 caps CAP 15 months Residual
Item Tacrolimus extended release capsule 1mg   Shelf Life
Specification Tacrolimus extended release capsule 1mg  
2234 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00440 720 01 IMMEDIATELY with
DHS/RQ/219/(E)/2020 SR No 01208701 TABS TAB 15 months Residual
Item Mycophenolic acid Tablet 180mg   Shelf Life
Specification Mycophenolic acid tablet 180mg  
Each tablet to contain 180 mg of mycophenolic acid as
mycophenolate sodium
Note:
01.The shelf life of the product should be minimum of
24 months.
2235 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00440 1,080 01 IMMEDIATELY with
DHS/RQ/220/(E)/2020 SR No 01208802 TABS TAB 15 months Residual
Item Mycophenolic acid Tablet 360mg   Shelf Life
Specification Mycophenolic acid tablet 360mg  
Each tablet to contain 360 mg of mycophenolic acid as
mycophenolate sodium
Note:
 01.The shelf life of the product should be minimum of
24 months.

2239 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00495 68 68 IMMEDIATELY with

DHS/RQ/224/(E)/2020 SR No 01401401 VIALS VIALS 15 months Residual
Item Adalimumab injection 40mg   Shelf Life

Specification Adalimumab injection 40mg  

2240 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00497 365 365 IMMEDIATELY with
DHS/RQ/225/(E)/2020 SR No 00108601 TABS TABS 15 months Residual
Item Tenofovir Disoproxil Fumarate Tablets 300mg   Shelf Life

Specification Tenofovir Disoproxil Fumarate Tablets 300mg  

2241 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00498 51 51 IMMEDIATELY with
DHS/RQ/226/(E)/2020 SR No 01210201 VIALS VIALS 15 months Residual
Item Azacitidine injection 100mg vial   Shelf Life

Specification Azacitadine Injection 100mg vial,  

Each vial to contain 100mg of Azacitadine for
subcutaneous and intravenous use.
Note:
1.The product should be stable for 24 months when
stored at a temperature of 28'C-32'C.
2. Each vial should be labelled accordingly
2242 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00499 8 8 IMMEDIATELY with
DHS/RQ/227/(E)/2020 SR No 01402802 VIALS VIALS 15 months Residual
 Item Secukinumab injection150mg/ml powder for solution  
Specification Secukinumab injection150mg/ml powder for solution   Shelf Life
2244 LP/MSD/CPU- MSD O/L No 2020/SPC/B/R/P/00501 60 60 IMMEDIATELY with
DHS/RQ/229/(E)/2020 SR No 01106601 caps CAPS 15 months Residual
Item Acitretin capsule 10mg   Shelf Life

Specification Acitretin capsule 10mg  

2254 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00554 672 672 BY 14/07/2020 with
DHS/NRQ/239/(E)/2020 SR No 00306002 TABS TABS 15 months Residual
Item Riluzole tablet 50mg   Shelf Life
Specification Riluzole tablet 50mg  
2255 LP/MSD/CPU- MSD O/L No 2020/SPC/B/C/P/00555 58 58 BY 14/07/2020 with
DHS/RQ/240/(E)/2020 SR No 01402802 VIALS VIALS 15 months Residual
Item Secukinumab injection150mg/ml powder for solution   Shelf Life
Specification Secukinumab injection150mg/ml powder for solution  
Conditions to the Tender
You are requested to indicate the lowest price in Sri Lankan Rupees that could be afforded.
A Certified copy of the National Medicines Regulation Authority (NMRA – Sri Lanka) Registration Certificate, Certificate of Analysis (COA)
should be forwarded along with the quotation.

In addition, the following information also should be indicated in your quotation.

1. Delivery Date
2. Availability of Ex-Stocks (Ex- Stocks are expected to be supplied within two (02) working days after placing the order.
3. Delivery Schedule / date (in case if Ex- Stocks are not available)
4. Shelf Life of the item (Date of Manufacture and Date of Expiry)
5. Related Tender Number, SR number of the item and description of item.
6. Contact details of the bidder (Contact Person, TP Nos, (Land/mobile), Fax, e-mail)

Your quotation / quotations shall be placed in the relevant tender box; which is placed in the Internal Audit Department of the Head Office of
the State Pharmaceuticals Corporation. Prior to closing date and time indicated above. (Any late delivered / submitted bids will be rejected
without accepting)

Tender Samples, with clear indication of the Tender No, shall be handed over to the Administration Department on or before the closing of
tender and acknowledgement of such samples should be attached to the quotation (bid).

SPC reserves the right to call samples from bidders who have not submitted samples before closing of the tender in cases of none of the
bidders had submitted samples, evaluators are with the opinion of calling samples from bidders who have not submitted samples and / or the
Procurement committee is with the opinion of calling of samples from the bidders who have not submitted samples will help them to make a
cost effective decision.

Note
1. Please indicate the current market whole sale and Retail prices in your quotation (bid)
2. Your Quotation (bid) shall be submitted in one original and one duplicate, sealed separately and marked as “ORIGINAL” and
“DUPLICATE” respectively. Both envelopes shall be enclosed in one envelop and deposited in the tender box kept in the Internal Audit
Department.
3. In case if the supplier / manufacturer is not registered with NMRA – Sri Lanka, please provide following details together with the bid
(Quotation)
i) GMP certificate
ii) Certificate of Pharmaceutical Products
iii) Manufacturer’s information letter
iv) Certificate of Analysis of the Product

Bid Evaluation Summary Sheet

Format of the “Bid Evaluation Summary Sheet” is published in SPC website [www.spc.lk]
All potential bidders should submit duly filled “Bid Evaluation Summary Sheets” together with the bid.
Soft copy (Only in MS Excel Format) should be e-mailed to techtender@spc.lk within 02 working days of Tender closing.
Non-Submission of Bid Evaluation Summary Sheets will be treated as Non-Compliance of conditions of bidding and such
bids will be treated as Non-Responsive at the time of tender evaluations.
CONDITIONS OF SUPPLY
1. The Product should have minimum of 15 months / 12 months shelf life at the time of delivery at Medical Supplies Division (As indicated under
“Delivery” of each item in the above schedule)

2. Description of item, Date of manufacture, Date of expiry, Batch No, Name and address of manufacture Should be clearly marked on the outer
covering containing the item and on the outer cover of the carton/box.

3. Offers for any other economically viable pack sizes different from the specify pack sizes are acceptable with the prior approval of Director Medical
Supplies Division.

4. MSD Order List No, SR No. of Item, SPC Indent No/purchase order no Description and storage condition of item and Batch No shall be indicated in
all Supply Invoices.

5. Storage condition of the items should be clearly indicated in the inner most and outer most carton labels.
6. Cold chain monitors should be included for each cartons and the cold chain should be maintained according to the manufacturer's instructions
during storage, transport and delivery.

7. Delivery of the items is to be made to free of charge.

8. Withdrawal from use of Item due to quality failure.

a) In case of batch withdrawal due to quality failure, the supplier/ manufacturer shall reimburse the value of entire batch quantity supplied.
b) In case of product withdrawal due to quality failure, the supplier/ manufacturer shall reimburse the value of entire product quantity
supplied.
c) In the event of either a) or b) above the supplier/manufacturer shall be surcharged additional 25% of the total value concerned as
administrative cost.

9. Standard- any other pharmaceutical standard accepted by cosmetics, devices and drugs regulatory authority in Sri-Lanka for registration of
pharmaceutical item also acceptable.

10. In the event that item is awarded to unregistered bidder, the NOL/PUL issued by NMRA should be submitted when item is delivered. If not,
payment will not be released for the delivered item. (In case of applying for NOL, relevant fee due to NMRA shall be borne by the supplier)
11. In the event of failing to supply the item within the delivery schedule given the Purchase order the item will not be accepted by MSD. However, if
the item is still required by Medical Supplies Division and decides to accept the same , a penalty of 0.1% of the total value per day up to 7
days(total of 0.7% for 1st 7days of late delivery), 0.3%per total value per day from 8th to 14th (another 2.1% for 7 days from 8th to 14th day of late
delivery),0.5% per total value per day from 15th to 21st day (another 3.5% for the period from 15th to 21st day of late delivery) for the lapsed
period will be deducted from your payment as liquidated damage.
In case of an item delivered after 3 weeks, if the item is still required MSD reserves the right to accept maximum penalty of 10% of the total value
will be imposed.

12. In addition to the condition given herein any other relevant condition as per the tender document issued by SPC are also applicable.
13. IN CASE OF AWARD, DELIVERY OF SPC MAIN ORDER(S) WILL BE CONSIDERED PRIOR TO RELEASEING THE INDENT / PURCHASE ORDER FOR THE
LOCAL SUPPLY